nasdaq-mynz-mainzbiomed.png
Mainz Biomed Showcases ColoAlert® at Two Prominent Gastroenterology Conferences in Poland
12 déc. 2023 08h01 HE | Mainz BioMed NV
Mainz Biomed Showcases ColoAlert® at Two Prominent Gastroenterology Conferences in Poland
nasdaq-mynz-mainzbiomed.png
Mainz Biomed Reports Positive Topline Results from U.S. eAArly DETECT Study Evaluating Novel mRNA Biomarkers
05 déc. 2023 09h01 HE | Mainz BioMed NV
Mainz Biomed Reports Positive Topline Results from U.S. eAArly DETECT Study Evaluating Novel mRNA Biomarkers
nasdaq-mynz-mainzbiomed.png
Mainz Biomed’s Presentation at the 35th Annual Piper Sandler Healthcare Conference to be Made Available via Webcast
29 nov. 2023 08h01 HE | Mainz BioMed NV
Mainz Biomed’s Presentation at the 35th Annual Piper Sandler Healthcare Conference to be Made Available via Webcast
nasdaq-mynz-mainzbiomed.png
Mainz Biomed to Present at the 35th Annual Piper Sandler Healthcare Conference
20 nov. 2023 08h01 HE | Mainz BioMed NV
Mainz Biomed to Present at the 35th Annual Piper Sandler Healthcare Conference
nasdaq-mynz-mainzbiomed.png
Mainz Biomed Reports Third Quarter 2023 Financial Results and Provides Corporate Update
16 nov. 2023 08h01 HE | Mainz BioMed NV
Mainz Biomed Reports Third Quarter 2023 Financial Results and Provides Corporate Update
nasdaq-mynz-mainzbiomed.png
Mainz Biomed Announces Closing of $5.0 million Registered Direct Offering
15 nov. 2023 09h01 HE | Mainz BioMed NV
Mainz Biomed Announces Closing of $5.0 million Registered Direct Offering
nasdaq-mynz-mainzbiomed.png
Mainz Biomed Announces Pricing of $5.0 million Registered Direct Offering
13 nov. 2023 09h00 HE | Mainz BioMed NV
Mainz Biomed Announces Pricing of $5.0 million Registered Direct Offering
nasdaq-mynz-mainzbiomed.png
Mainz Biomed Partners with Liquid Biosciences to Harness the Power of Artificial Intelligence (AI) to Develop Next-generation Colorectal Screening Test
09 nov. 2023 08h01 HE | Mainz BioMed NV
Mainz Biomed Partners with Liquid Biosciences to Harness the Power of Artificial Intelligence (AI) to Develop Next-generation Colorectal Screening Test
nasdaq-mynz-mainzbiomed.png
Mainz Biomed to Showcase ColoAlert® at Leading Global Healthcare Event, MEDICA
07 nov. 2023 08h01 HE | Mainz BioMed NV
Mainz Biomed to Showcase ColoAlert® at Leading Global Healthcare Event, MEDICA
nasdaq-mynz-mainzbiomed.png
Mainz Biomed Reports Success from Employee Colorectal Cancer Screening Campaign in Partnership with Zöller-Kipper
31 oct. 2023 08h01 HE | Mainz BioMed NV
Mainz Biomed Reports Success from Employee Colorectal Cancer Screening Campaign in Partnership with Zöller-Kipper